Recro Pharma Announces Proposed Public Offering of Common Stock
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/13/2026
- S&P 500 ends higher as CoreWeave results fuel AI optimism
- Oil prices edge up as investors weigh US-Iran talks deadlock against lower demand
- CoreWeave soars after fifth straight quarter of record revenue, raised guide
- Four key things investors will watch in Nvidia's earnings next week
- Silver could surge to $90 as investment demand takes over, Citi says
- After-Hours Movers: CSCO, COHR, HLIT, CBRS, STUB, ENS
- After-Hours Movers: CRWV, NBIS, SMCI, LITE, CAVA, HRB
- After-Hours Movers: P, RIOT, BW, RKLB, HIMS, UPWK
- After-Hours Movers: TEAM, NET, TWLO, DOCS, FROG, DV, TTD, ABNB, DKNG, SG, RKT
- After-Hours Stock Movers: WDC, SNDK, FIG, APP, HUBS, SOUN, DASH, XYZ, Z, FLNC
Recro Pharma (REPH) Prices 1.99M Common Stock Offering at $7.50/Share
August 16, 2016 9:01 AM EDTRecro Pharma, Inc. (Nasdaq: REPH) announced the pricing of an underwritten public offering of 1,986,666 shares of its common stock at a price of $7.50 per share.
All shares in the offering are being sold by Recro, with expected gross proceeds to Recro of approximately $15 million. The offering is expected to close on or about August 19,... More
